Suchergebnisse - "Cantini, Fabrizio"

PubPharm (209)

91

Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease

enthalten in: Autoimmunity reviews | 2014

von Olivieri, I. | Cantini, F. | Castiglione, F. | +7

92

The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis

enthalten in: Clinical and experimental rheumatology | 2014

von Spadaro, A. | Lubrano, E. | Marchesoni, A. | +14

93

Biologics and tuberculosis risk : the rise and fall of an old disease and its new resurgence

enthalten in: The Journal of rheumatology. Supplement | 2014

von Cantini, F. | Goletti, D.

94

Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy : international recommendations

enthalten in: The Journal of rheumatology. Supplement | 2014

von Iannone, F. | Cantini, F. | Lapadula, G.

95

Adalimumab, etanercept, infliximab, and the risk of tuberculosis : data from clinical trials, national registries, and postmarketing surveillance

enthalten in: The Journal of rheumatology. Supplement | 2014

von Cantini, F. | Niccoli, L. | Goletti, D.

96

Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-α (TNF-α) targeted biologics and recently licensed TNF-α inhibitors : data from clinical trials and national registries

enthalten in: The Journal of rheumatology. Supplement | 2014

von Cantini, F. | Niccoli, L. | Goletti, D.

97

Restarting biologics and management of patients with flares of inflammatory rheumatic disorders or psoriasis during active tuberculosis treatment

enthalten in: The Journal of rheumatology. Supplement | 2014

von Cantini, F. | Prignano, F. | Goletti, D.

98

High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy : data from GISEA, the Italian biologics register

enthalten in: Clinical rheumatology | 2014

von Iannone, F. | Gremese, E. | Gallo, G. | +18

99

HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions : A Systematic Review and Meta-Analysis

enthalten in: International journal of rheumatology | 2014

von Cantini, F. | Boccia, S. | Goletti, D. | +5

100

Biologics and Tuberculosis risk : the rise and fall of an old disease and its new resurgence

Erschienen: Toronto, Ont., The journal of rheumatology, 2014

Journal of rheumatology, Supplement - 91

von Cantini, F.